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The chemical properties of skin angiotensin-convert-
ing enzyme were characterized in mouse and human. In 
newborn mice, dermis contained almost all activity (1.3 
mU/mg), of which 30% was in the 22,000 xg supernatant 
and 70% in the pellet which could be solubilized by Triton 
X-100. The activity increased sharply during the first 6 
weeks after the birth. By gel filtration, the enzyme in the 
supernatant was Mr 330,000, but the solubilized enzyme 
vvas Mr 430,000 in the presence of Triton X-100. By elec-
trophoresis, the 2 enzyme fractions demonstrated a 
charge difference. The enzymes showed the same pH 
optima of around 8.1 and 7.7, and Km values of 2.6 and 
0.11 mM for Hip-His-Leu and angiotensin I, respectively. 
Sensitivity to known inhibitors and heat stability of the 
enzymes in 2 fractions were similar. In the human, 56% 
of the activity in skin homogenates (1.5 mU/mg) ap-
peared in the supernatant and 44% in the pellet. Both 
soluble and solubilized preparations showed enzyme ac-
tivity with 2 different molecular weights, 330,000 and 
430,000. The human enzymes had chemical properties 
similar to the mouse enzymes, but their affinity for Hip-
His-Leu and angiotensin I were 1.6 and 2 times higher 
than those of the mouse enzymes. 
Angiotensin-converting enzyme (peptidyl dipeptide hydro-
lase, EC 3.4.15.1) hydrolyzes angiotensin I and forms angioten-
sion II [1,2] which is a potent vasopressor [3], and increases 
permeability of microvasculature in skin [4,5]. A soluble form 
of the enzyme, probably secreted by endothelial ceUs [6,7], was 
first isolated from plasma [8]. The enzyme is a zinc-containing 
glycoprotein and requires chloride ion for activation [1,2,9]. 
The enzyme activity was detected in lung and kidney of exper-
imental animals [10-14] and humans [15,16] in soluble and 
particulate fractions. Angiotensin II produced in these organs 
was considered to be involved in control of systemic circulation 
[ 1 7] and related to renal hypertension [18]. The enzymes were 
also found to be chemically a nd enzymatically the same as 
kinase II, which inactivates bradykinin [19,20]. 
Our preliminary study showed that mouse and human skin 
contain angiotens in-converting enzyme in the dermis [21]. The 
specific activity in newborn mouse skin was about 1/200 and 
1/ 
50 of the activi ty in adult mouse lung and kidney, respective ly 
[21,22]. In this study we have pa1tiaUy purified the enzymes 
from both mouse and human skin, and have studied their 
electrophoretic mobility, kinetics, and susceptibility to inhibi-
tors. In a ddition, changes in e nzyme activity in mouse skin were 
measured from birth up to 10 weeks of age. 
MATERIALS AND METHODS 
Serum and skin were obtained from BALB/c strain mice of varying 
ages. Human serum was collected fTom volunteers and human skin 
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secured from male type a lopecia lesions. Cul tured fibrob lasts were 
prepared from mouse skin as described by Nadler et al [23]. Pyr-Trp-
Pro-Arg-Pro-G ln-Ile-Pro-Pro (SQ 20881) was pw·chased from Penin-
sula Lab, San Carlos, CA and Sephal'Ose 6B from Pharmacia Fine 
Chemicals, Piscataway, NJ . All chemicals for the enzyme assay includ-
ing synthetic angiotension I and standard proteins were obtained from 
Sigma Chemical Co, St. Louis, MO. 
Enzyme Assay 
Angiotensin-converting enzyme was assayed by the method of Fried-
land and Silverstein [24) with a slight modification. Twenty ,u.l of 
enzyme solution was added to 0.24 m.l of buffe r solu tion consisting of 
0.1 M phosphate buffer, pH 8.3, 0.3 M NaCl and 5.5 mM Hip-His-Leu 
and incubated for 10 min at 37°C. His-Leu produced was measw·ed 
fluorometrically [22]. For the enzyme assay in cmde extracts, we added 
2.5% n-butanol in order to prevent hydrolysis of His-Leu by peptidase. 
(The hyru·olysis rates measured in serum. and skin were 1.83 and 1.30 
nmol/min/ mg in mouse and 1.80 and 0.43 nmol/min/ mg in man.) 
Inhibitors were added, replacing 25 Ill of the buffer-substrate solu tion. 
To assay for hydrolysis of angiotensin I, t he pllJ'ified enzyme was 
incubated for 1 hr in 0.24 ml of the reaction mixtllJ'e, containing 0.1 M 
phosphate buffer, pH 7.6, 0.09 M NaCl, and various concentrations of 
angitoensin I, and the His-Leu produced was fluorometricaUy deter-
mined [22]. One unit (U) of activity was defined as the amount of 
enzyme that re leased 1/Lmol of His-Leu/ min from the substrates, and 
the activity ..in the skin samples represented the mean ± SE. ,8-Galac-
tosidase, catalase, and glucose-6-phosphate dehyru·ogenase were as-
sayed by the methods of Bergmeyer, Gawehn, and Grassl [25]. Protein 
was determined by the method of Lowry et at [26) using bovine serum 
albumin as a standaJ'd 
Tissue Fractionation 
The skin samples were rinsed twice in cold 0.25 M sucrose-50 mM 
Tris-HCl buffer, pH 8.0. In some experiments with newborn mice, 
epidermis and dermis were separated after immersion in cold 0.24 M 
NH,Cl, pH 9.5, for 10 min. The skin and dermis were minced and 
homogenized with the sucrose solution in Polytron and glass homoge-
nizers as previously described [27]. The epidermis and fibroblasts were 
homogenized using only a glass homogenizer. The samples were centri-
fuged for 1 hr at 22,000 xg to sepru·ate supernatant (supernatant 
fraction) and pellet (parti ulate fraction) . The sucrose solu tion was 
used to resuspend the pru·ticulate fraction to make a protein concentra-
t ion of 9 mg/ ml. 
Solubilization of Angioten.sin-Con.verting Enzyme from th e 
Particulate Fraction 
Freezing and thawing were repeated 5 times. Trypsin digestion was 
done by the method of Nishimura et a t [16]. Triton X-100 (0.5-l.O%) 
or 
deoxycholate (0.1- 1.0%) was added. After 1 hr incubation at 4°C, the 
samples were centrifuged for l hr at 22,000 xg and the supernatant 
(solubilized fraction) was sepru·ated from the unsolubilized portion 
(residue). 
Gel Filtration 
The supernatant fraction and the solubilized fraction were concen-
trated to le s than 1 ml by ultrafiltra t ion with an Amicon PM-30 
membrane, and applied to a column (1.5 x 90 em) of Sepharose 6B 
equilibra ted with 0.25 M sucrose containing 50 mM Tris-HCl buffer, pH 
8.0, with or without 0.05% Triton X-100. One-half ml of the serum 
samples was directly subjected to chromatography. The column 
was calibrated using Blue dextran, ,8-galactosidase, catalase, glucose-6-
phosphate dehyru·ogenase, hemoglobin, and cytochrome c. Blue dextran 
was assessed by absorbance at 280 nm, and hemoglobin and cytochrome 
c by that at 410 nm. 
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Disc Polyacrylamide Gel Electrophoresis 
The method of Davis [28] was used with minor modification. The 
samples, purified by gel ftltration, were concentrated to make the 
activity about 20 mU/ml. The concentrate, 100 p.l, was run at 4°C and 
3 rnA/tube (5 X 65 mm) of 7% polyacrylamide gel matrix containing 
0.2% Triton X-100, until bromophenol blue, as a tracking dye, reached 
the end of the gel. The gel was sliced 1.0 mm wide and the activity in 
each slice assayed by the method of Friedland and Si.lverstein [29]. 
RESULTS 
Distribution of Angiotensin-Converting Enzyme 
In newborn mouse skin almost all the enzyme activity was 
detected in the dermis (Table I). No difference was found 
between back (1.35 ± 0.27 mU/mg, n=4) and abdominal (1.22 
± 0.09 mU/mg, n=4) skin. About 70% of the activity was 
recovered in the particulate fraction in the 22,000 xg pellet 
which was suspended in sucrose solution. Cultured fibroblasts 
showed enzyme activity of 0.59 ± 0.03 mU/mg, n=3. In the 
whole human scalp skin, the enzyme activity was 1.46 ± 0.14 
mU/mg, n=6. No attempt was made to measure activity in the 
epidermis or dermis separately. In contrast to the mouse skin, 
about 44% of the activity was in the particulate fraction. 
Solubilization of Angiotensin-Converting Enzyme 
Table II compares the efficacy of different treatments on 
solubilization of the enzyme from the particulate fraction. For 
both mouse and human skin, we found that freezing and thaw-
ing solubilized a small amount of the enzyme and trypsin 
treatment inactivated it. Triton X-100 and deoxycholate re-
sulted in release of the enzyme. Use of 0.5% Triton X-100 
showed max~um solubilization and the activity attained was 
TABLE I. The distribution of angiotensin-converting enzyme activity 
in mouse shin 
Skin samples 
EpidermiS homogenates 
Dermis homogenates 
Dermis supernatant fraction 
Dermis particulate fraction 
Activity" 
Specific activity (mU/mg) 
0.06 ± 0.02c 
1.33 ± 0.17 
1.07 ± 0.27 
2.16 ± 0.25 
Recoveryf! 
(%) 
1.5 ± 0.6 
98.4 ± 0.6 
29.5 ± 2.4 
70.5 ± 2.4 
"The enzyme activity was determined in the presence of 2.5% n-
butanol. 
"Recovery was calculated as (activity in each sarnple)/ (total re-
covered activity) X 100. 
c All values represent the mean ± SE from 5 experiments. 
TABLE II. Solubilization of angiotensin-converting enzyme from the 
particulate fractions of mouse dermis and human whole shin" 
Relative activity" Recovered 
Mouse dermis Human skin 
Treatment 
Solu- Solu-. 
bilized residue bilized Residue 
fraction h·action 
Freezing and thawing 14 118 14 88 
Trypsin (100 p.g/mg protein) 23 24 40 22 
at 37°C for 2 hr 
0.05% Triton X-100 60 58 31 70 
0.1% Triton X-100 97 38 112 39 
0.5% Triton X-100 138 11 126 26 
1.0% Triton X-100 128 10 120 20 
0.1% Deoxycholate 55 51 38 63 
0.5% Deoxycholate 64 13 60 16 
1.0% Deoxycholate 56 10 44 16 
" The particulate fractions (9 mg/ml) obtained from mouse dermis 
or human skin were used in each experimental condition. Angiotensin-
converting enzyme activity was measured in supernatant and the 
residue suspended in 0.25 M sucrose-50 mM Tris-HCl buffer, pH 8.0. 
b The relative activity represents the percent of activity measUJ·ed in 
the original particulate fraction. 
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130% of the original; only 60% of the original enzyme activity 
was recovered in the deoxycholate extract. 
Gel Filtration and Electrophoresis 
Elution profiles from both murine and human angiotensin-
converting enzymes in serum and skin from Sepharose 6B are 
illustrated in Fig 1. Both mouse and human serum enzymes 
appeared as a single peak between the ,8-galactosidase with 
catalase markers; the M,. was estimated to be 300,000. Without 
Triton X-100 in the buffer, the soluble mouse skin enzyme was 
identical to the serum enzyme (Fig 1a), while the soluble human 
skin enzyme showed 2 peaks (Fig 1d); one of which was eluted 
at the same position as the serum enzyme and the soluble 
mouse skin enzyme, and the other of which was at void volume. 
The solubilized enzyme from the particulate fractions of both 
mouse (Fig 1b) and human skin (Fig 1e) was eluted out as a 
broad peak. We pooled the fractions that appeared at void 
volume, added 0.5% Triton X-100 and rechromatographed in 
the presence of0.05% Triton X-100. A single peak was recovered 
at the position of a M,. of about 430,000 (Fig 1c and f) . The 
same was true when we reclu·omatographed human skin-soluble 
enzyme eluted out at void volume with buffer containing 0.05% 
Triton X-100. The single peak of about M,. 430,000 was obtained 
(Fig 1{). We calculated that these purification steps of the crude 
enzyme preparations achieved 25- and 12-fold concentrations of 
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FIG l. Gel filtration of angiotensin-converting enzymes fTom mouse 
(a,b,c) and human skin (d,e,f) on Sepharose 6B. The activity in each 
fraction was assayed with Hip-His-Leu as a substrate. The gel filtrations 
of a,b,d, and e were done in 50 mM Tris-HCl buffer, pH 8.0, containing 
0.25 M sucrose. Applied samples were the supernatant fraction of the 
skin homogenates (a and d) and the solubilized supernatant from the 
particulate fraction (b and e). The arrows indicate elution position of 
serum enzymes of mouse (a) and man (d). The gel ftltrations of c and 
{were done in the above mentioned buffer but 0.05% Triton X-100 was 
added. The samples applied were enzyme fractions eluted from the 
chromatography at the positions of 1.0 to 1.4 Ve/Vo (elution volume of 
the enzyme/void volume). (--) is enzyme fraction from the samples 
shown in Fig 1b and 1e and (- - -) is enzyme fractions from the 
chromatography seen in Fig 1d. 
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the M,. 330,000 enzyme and 44- and 50-fold concentrations of 
the M,. 430,000 enzyme from mouse and human skin, respec-
tively. 
By electrophoresis the M,. 330,000 enzymes from skin and 
sera of both species migrated at a relative mobility approxi-
mately 0.30. The M,. 430,000 solubilized enzymes gave at least 
3 bands but the major murine and human enzyme band showed 
a relative mobility of 0.10 and 0.13, respectively (Fig 2). 
Heat Stability 
All enzymes were stable by incubation below 45°C for 10 min 
but were inactivated at about 55°C (Fig 3). 
Catalytic Properties 
The low and high M,. enzymes of each species showed a 
similar pH dependency and Km value for hydrolysis of 2 
substrates. The mouse enzyme functioned optimally at pHs of 
8.0-8.3 for Hip-His-Leu and 7.7-8.0 for angiotensin I (Fig 4). 
The human skin enzymes showed pH optima of 8.0 for Hip-His-
Leu and 7.4-7.8 for angiotensin I. The mouse enzymes had 
higher Km values than human enzymes for both Hip-His-Leu 
(2.6 mM vs. 1.7 mM) and angiotension I (110 fJ.M vs. 50 tJ.M). 
However the ratio of V max for Hip-His-Leu to Ymux for angioten-
sin I was similar for both human and mouse enzymes (Fig 5). 
Human and mouse skin enzymes were inhibited in a similar 
fashion by various chemicals (Table III) . SQ 20881 was the 
most potent inhibitor, as shown in studies in other tissues [1,2, 
9]. Concanavalin A inhibited the high M,. enzymes from human 
skin more than the low M,. enzyme. All enzymes required NaCl 
and about 90% of the activity was lost by deleting NaCI from 
the reaction mixture. 
Angiotensin-Converting Enzyme in the Skin and Aging 
Total enzyme activity in mouse skin was measured by adding 
0.5% Triton X-100 to the homogenates. It was constant from 
birth to 5 days old, but increased 2-fold by 4 weeks, reaching 
adult values by 6 weeks (Fig 6). The ratio of activity in the 
supernatant and particulate fractions was compared in adult 
mice (10 weeks old) and about 65% was found in the particulate 
fraction. Sensitivity to inhibitors and Km values for Hip-His-
Leu of the enzymes in 10-week-old mice were similar to those 
of newborn mouse skin enzymes. 
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FIG 2. Gel electrophoresis of angiotensin-converting enzymes from 
skin (--) and serum (---)of mouse and man. The enzyme activity 
in gel s lices was assayed using Hip-His-Leu as a substrate a nd expressed 
by relative fluorescence intensity. Relative mobility of the enzymes was 
calculated from the mobility of bromophenol in each ge l. Applied 
samples and their specific activities were soluble enzyme of mouse 
dermis (34 mU/ mg) and serum (a); solubilized enzyme of mouse dermis 
(58 mU/ mg) (b); soluble enzyme with M, 330,000 of human skin (17 
m U/mg) and serum (c) and solubilized enzyme with M, 430,000 of 
human skin (73 mU/mg) (d). 
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FIG 3. Heat stability of angiotensin-converting enzymes isolated 
from the supernatant (--) and particulate (-- -) fractions of mouse 
dermis (e 0 ) and human skin <• 0). Each enzyme solution was 
adjusted to an enzyme concentration of approximately 10 mU/ ml and 
heated to various temperatw·es for 10 min before assay for the activity 
using Hip-His-Leu as substrate. 
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FIG 4. Effect of pH on hydrolysis of Hip-His-Leu (--) or angio-
tensin (-- -) by soluble (e) and solubilized (0 ) enzymes from mouse 
dermis (A) and human skin (B) . 0.1 M phosphate, pH 6.8 to 8.3, and 0.2 
M borate-phosphate, pH 7.9 to 9.7, buffers were used. Hydrolysis of 
angio tensin I (0.2 mM) was assayed in the presence of 0.09 M NaCl. 
A B 
0.4 4 
0.3 3 
~ 
...... 
E E 
'-. 
'-. ::::> 0.2 ::::> 2 5 E ~ 
> > ~ '-. 
..... 
-0.4 0 0.4 0. 8 1. 2 -20 -10 0 10 20 30 40 
1/ [Hip-His-Leu) mW 1 ! /[Angiotensin I) mW 1 
FIG 5. Comparison of the relationship of reaction velocity vs. sub-
strate concentration between the enzymes from mouse and human skin. 
The data was analyzed by the method of Lineweaver and Burk [30]. 
The velocity (V) was expressed as mU/ mJ calculated from the nuoro-
metric measm-ement of the formation of His-Leu with various concen-
trations of Hip-His-Leu (A) and angiotensin I (B). e, mouse M, 330,000 
enzyme; 0 , mouse M, 430,000 enzyme; •, human M, 330,000 enzyme; 
0, human M, 430,000 enzyme. 
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TABLE Ill. Effect of various inhibitors on soluble and solubilized angiotensin-converting enzymes (A CE) from murine and human shin 
Inhibitor Concentration (/lM) 
SQ 20881" 1 
SQ 20881 0.1 
Concanavalin A 200 
Concanavalin A 48 
EDT A'" 100 
D ithiothreitol 200 
Albumin 200 
Sodium deoxy- 0.05 (%) 
cholate 
Triton X-100 0.05 (%) 
" The activity was assayed with Hip-His-Leu as a substrate. 
• Pyr-Trp-Pro-Arg-Pro-Gln-lle-Pro-Pro. 
' Ethylenediamine tetraacetic acid, disodium salt . 
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FIG 6. Angiotensin-converting enzyme activity of mouse skin at 
var ious stages of development. Activity was assayed after the homog-
enate was incubated with 0.5% Triton X-100 at 4°C for 1 hr and ·the 
value represents mean ± SE of at least 3 determinations in mice of 
mixed sexes. 
DISCUSSION 
Both soluble and particulate forms of angiotensin-conver ting 
enzyme were present in human and mouse skin . The proportion 
of soluble to particulate enzyme in skin was higher than in 
kidney or lung, but lower than in liver [22,31). The soluble 
mouse skin enzyme showed the same elution profile as serum · 
enzymes by gel filtration. Soluble enzymes with similar M, have 
been detected in mouse liver [31] and human sperm [32]. Soffer 
[2] pointed out that M , of angiotensin-converting enzyme de-
termined by gel filtration may be greater than that by sucrose 
gradient because the enzyme is a glycoprotein: the M, of human 
plasma enzyme determined by gradient centrifugation was 
150,000 [33]. The soluble human skin enzyme contained an 
additional enzyme eluted out in the void volume, as shown in 
gel flltration of human skin kininases [34] and the supernatant 
fraction of lungs of hog [13] and human [15]. Since the excluded 
enzyme of human skin appeared at the position estimated to 
be about 430,000 after rechromatography with Triton X-100 
added buffer, we conclude that there are two forms of soluble 
enzymes with different apparent M, in human skin, although 
their catalytic properties on Hip-His-Leu and angiotensin I 
were t he same. 
% Inhibition" 
Murine ACE 
M, 430000 
99 
65 
68 
48 
85 
80 
20 
58 
10 
M,300000 
99 
76 
60 
29 
78 
74 
24 
60 
0 
Human ACE 
M, 430000 
99 
78 
67 
44 
83 
80 
26 
66 
0 
Various methodologies have been established for solubilizing 
angiotensin-converting enzymes from tissues. Freezing and 
thawing worked for hog lung enzyme [35] but was not suited 
for the skin . Although human lung enzyme was solubilized by 
trypsin digestion [16], the same technique inactivated the skin 
enzyme. Detergents have been widely used for extraction of th e 
enzymes in hog kidney [14] and lung of several animals [36-39] 
and human [40]. We found Triton X-100 to be very effective 
no t only in solubilization, but also to increase enzyme activity . 
D eoxycholate· in the same concentrations inhibited enzyme 
activity. The solubilized enzyme fro m both mouse and human 
skin had aM, of approximately 430,000 by gel filtration. Studies 
with solubilized enzymes from lung of rabbit [37] and dog [38] 
detected enzymatic activity in fractions of approximately M,. 
330,000 and in void volume by gel filtration with Sephadex G-
200. Das and Soffer [37] compared these enzym es and found 
differences in mobility to native gel electrophoresis. They de-
tected protein bands other than the enzyme by sodium dodecyl 
sulfate gel electrophoresis and suggested that the enzyme in the 
void volume was tightly bound to another protein. Our findings 
of 2 M , proteins with enzyme activity also may be due to 
extaneous protein binding because the catalytic properties of 
both enzymes were essentially the same. Since M,. 430,000 
protein aggregates without Triton X-100, we assume the bound 
protein is hydrophobic. Native gel electrophoresis of M ,. 430,000 
protein showed several minor bands, indicating that aggregation 
may appear in more than one form. Furthermore, extraction of 
the soluble enzyme of M,. 430,000 from human skin suggests the 
possibility that the enzyme exists in vivo in a bound form to a 
hydrophobic protein. 
For both mouse and human enzymes, pH optima were t he 
same for two substrates, but Km values were higher with the 
mouse enzyme than the human enzym es. The findings are 
comparable to previous reports by us and others; Km values of 
the enzymes from lung or serum of mouse [22], rabbit [7,37], 
and guinea pig [ 41] are the same as that of mouse skin enzymes 
and higher than the enzymes of human lung [16] and serum 
[29,35], which are similar to the skin enzyme. Another differ-
ence was found in the sensitivi ty of skin enzymes to concana-
valin A compared to that of serum and lung enzymes of guinea 
pig [ 41] but the pH optima did not show the difference, sug-
gesting their sialic acid contents are comparable [ 42,43). 
Angiotensin-converting enzyme activity increased in mouse 
skin with aging as reported in kidney and lung [ 44). The 
increase was not associated with a change in solubility of the 
enzym e, indicating that qualitative changes do not occur with 
aging. Recently, formation of angiotensin II from angiotensino-
gen by neutrophil neutral protease in inflammatory skin sites 
was reported [ 45]. Angiotensin-converting enzyme seems to 
play the major regulatory role in the vasa-physiological function 
in normal skin. 
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